The cancer treatment that hasn't been used once: How patients with rare tumours are being denied lifesaving therapy available on the NHS
The treatment, called selective internal radiation therapy (SIRT), was approved last year, offering a lifeline for patients with a rare neuroendocrine tumour (NET) in the liver.
The treatment, called selective internal radiation therapy (SIRT), was approved last year, offering a lifeline for patients with a rare neuroendocrine tumour (NET) in the liver.
